| Cited in | International search | Type: | Non-patent literature | Publication information: | [X] BAHARAV EHUD ET AL: "The anti-inflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models.", INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, vol. 12, no. Supplement 1, 2003, & 8TH WORLD CONGRESS ON ADVANCES IN ONCOLOGY AND 6TH INTERNATIONAL SYMPOSIUM ON MOLECULAR MEDICINE; CRETE, GREECE; OCTOBER 16-18, 2003, pages S42, XP009026428, ISSN: 1107-3756 [X] 22-36 * abstract * | Type: | Non-patent literature | Publication information: | [X] MABLEY JON G ET AL: "The A3 adenosine agonist, IB-MECA, protects against the development of arthritis and reverses established arthritis", FASEB JOURNAL, vol. 16, no. 5, 22 March 2002 (2002-03-22), & ANNUAL MEETING OF PROFESSIONAL RESEARCH SCIENTISTS ON EXPERIMENTAL BIOLOGY; NEW ORLEANS, LOUISIANA, USA; APRIL 20-24, 2002, pages A1044, XP008060305, ISSN: 0892-6638 [X] 22,24-36 * abstract * | Type: | Non-patent literature | Publication information: | [X] KRAUSE D: "Long-term combination therapy of rheumatoid arthritis: Methotrexate and parenteral gold", ZEITSCHRIFT FUER RHEUMATOLOGIE, vol. 57, no. 1, February 1998 (1998-02-01), pages 37 - 40, XP002369777, ISSN: 0340-1855 [X] 23-25 * tables 1-7 * | DOI: | http://dx.doi.org/10.1007/s003930050057 | Type: | Non-patent literature | Publication information: | [PX] BAHARAV EE ET AL: "Antiinflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models", JOURNAL OF RHEUMATOLOGY, TORONTO, CA, vol. 32, no. 3, 2005, pages 469 - 476, XP008060306, ISSN: 0315-162X [PX] 22,24-36 * abstract * | Type: | Non-patent literature | Publication information: | [X] ALETAHA D ET AL: "The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.", RHEUMATOLOGY (OXFORD, ENGLAND) DEC 2002, vol. 41, no. 12, December 2002 (2002-12-01), pages 1367 - 1374, XP002369778, ISSN: 1462-0324 [X] 23-25 * abstract * | DOI: | http://dx.doi.org/10.1093/rheumatology/41.12.1367 |
